MC2TCN
  • Nanotech & Cancer Treatment

    Nanotech & Cancer Treatment

    People of the Center
    The people who make The Center what it is today.
    Collaborations
    Our collaborations with other related organizations.
    Our Facilities
    The facilities at the Center.
    Research Areas
    Research areas at the Center.
  • Research Projects
  • Resources

    Resources

    Publications
    Publications by our leaders and staff.
    Clinical Trials
    Clinical Trials related to our Research Projects.
    Seminars & Events
    Seminars & Events related to our work.
    FAQ
    Frequently asked questions about the Center.
    News
    News related to the Center and our work.
  • Contact Us
  1. Home
  2. Resources
  3. Clinical Trials
  4. Introductory

Clinical Trials

Explore Clinical Trials

  • Intraoperative Imaging
  • Diagnosis
  • Treatment & Therapy
  • Introductory
  • C-Dots
More
Targeted Silica Nanoparticles for Image-Guided Intraoperative Sentinel Lymph Node Mapping in Head and Neck Melanoma, Breast, and Gynecologic Malignancies
Recruiting
Conditions: Gynecologic Malignancies; Breast Cancer
Intervention: Drug: fluorescent cRGDY-PEG-Cy5.5-C dots
PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study
Recruiting
Conditions: Newly Diagnosed or Recurrent Metastatic Melanoma Patients Malignant Brain Tumors
Intervention: Drug: PET scan with 124I-cRGDY-PEG-dots

Partners

  • Memorial Sloan Kettering Cancer Center
  • Cornell University
  • National Cancer Institute

MC2TCN PODCAST

Listen to our latest podcast series.

Keep Up To Date

  • FAQ
  • Privacy & Terms
  • Sitemap
  • © 2017 MSK-Cornell Center for Translations of Cancer Nanomedicine
  • New York Web Design by Avatar New York